EUVIMEDEUVIMED entdecken
Crossref

Human CD64 Alleviates Antibody‐Mediated Rejection in Xenotransplantation

Chuheng Gou, Hong Zhang, Rui Ding, Quancheng Wang, Li Zhang, Xin Hong, Liqiang Zhao, Kefeng Dou, Xuan Zhang iD

Xenotransplantation · 2026-01 · 33 (1)

DOI: 10.1111/xen.70110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 16.01.2026. Verfasst von Chuheng Gou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Graft Rejection, Receptors, IgG. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fourth Military Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Xenotransplantation, using gene‐edited pigs, represents an important approach to overcoming human organ shortages. A major obstacle to xenotransplantation is antibody‐mediated rejection (AMR), which leads to xenograft injury by activating complement and effector cells through the fragment crystallizable domain (Fc) of donor‐specific antibodies (DSAs). Therefore, we designed a strategy to express the human high‐affinity IgG receptor (hCD64) on porcine endothelial cells to competitively bind IgG and protect xenografts from AMR.

Methods

The lentiviral transduction of hCD64 into porcine aortic endothelial cells (PAEC) from wild‐type and GTKO pigs was validated using quantitative reverse transcription (qRT)‐PCR, Western blot, and flow cytometry. The effects of hCD64 transduction and activation on cell physiology were assessed using RNA sequencing. The IgG Fc‐binding capacity of hCD64 was validated using flow cytometry and ELISA. Finally, the protective effect of hCD64 against complement‐dependent cytotoxicity (CDC) and antibody‐dependent cell‐mediated cytotoxicity (ADCC) in PAECs and GTKO PAECs was confirmed through apoptosis assays. Results hCD64 was stably expressed at both mRNA and protein levels in PAEC hCD64 and PAEC GTKO/hCD64 , with both exhibiting normal physiological functions. PAEC hCD64 and PAEC GTKO/hCD64 bound free human IgG in a concentration‐dependent manner. In contrast, hCD64 did not bind to human IgM or pig and mouse IgG. In the CDC assay, the survival of PAEC hCD64 was significantly higher than that of PAEC NC (67.89% vs. 46.03%); moreover, the survival in GTKO PAEC had the same trend (85.18% vs. 71.09%). Similar results were obtained in the assay of ADCC: the survival rates of PAEC hCD64 and PAEC NC were 67.27% and 44.95%, respectively, and the survival of PAEC GTKO/hCD64 and PAEC GTKO/NC were 80.73% and 66.62%, respectively. Pre‐saturation with high doses of human‐derived mAbs did not abrogate the protective function of hCD64. Conclusion hCD64 expression may partially protect xenografts from AMR through its ability to bind competitively with DSAs IgG Fc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousGraft RejectionReceptors, IgGAnimalsHumansSwineAntibody-Dependent Cell CytotoxicityEndothelial CellsHeterograftsImmunoglobulin GMiceAnimals, Genetically Modified

Stichwörter der Autor:innen

antibody‐dependent cell‐mediated cytotoxicity (ADCC)antibody‐mediated rejection (AMR)complement‐dependent cytotoxicity (CDC)human CD64 (hCD64)xenotransplantation

Substanzen

Receptors, IgGImmunoglobulin G

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

ORCID-Profile: Xuan Zhang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Fourth Military Medical University
  • Key R&D Program of Shaanxi Health Commission
  • Innovative Medical Research Program of Xijing Hospital

Zitieren

APA

Gou, C., Zhang, H., Ding, R., Wang, Q., Zhang, L., Hong, X., Zhao, L., Dou, K., & Zhang, X. (2026). Human CD64 Alleviates Antibody‐Mediated Rejection in Xenotransplantation. Xenotransplantation, 33(1). https://doi.org/10.1111/xen.70110

Vancouver

Gou C, Zhang H, Ding R, Wang Q, Zhang L, Hong X, et al. Human CD64 Alleviates Antibody‐Mediated Rejection in Xenotransplantation. Xenotransplantation. 2026;33(1). doi:10.1111/xen.70110

BibTeX
@article{Gou2026,
  author = {Gou, Chuheng and Zhang, Hong and Ding, Rui and Wang, Quancheng and Zhang, Li and Hong, Xin and Zhao, Liqiang and Dou, Kefeng and Zhang, Xuan},
  title = {Human CD64 Alleviates Antibody‐Mediated Rejection in Xenotransplantation},
  journal = {Xenotransplantation},
  year = {2026},
  volume = {33},
  number = {1},
  doi = {10.1111/xen.70110}
}
Kostenlos starten →